Brain Scientific Stock Price, News & Analysis
Company Description
Brain Scientific (OTC Link: BRSF) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $932.0K.
BRSF stock has gained 200.0% over the past year. Shares last traded at $0.0003.
On a trailing twelve-month basis, Brain Scientific reported revenue of $215K with net income of -$12.3M and diluted earnings per share of $-12.95. The company operates at a net profit margin of -5753.0%.
This page provides a comprehensive overview of BRSF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Brain Scientific (BRSF) stock last traded at $0.0003. Over the past 12 months, the stock has gained 200.0%. At a market capitalization of $932.0K, BRSF is classified as a micro-cap stock with approximately 1.2M shares outstanding.
Latest News
Brain Scientific has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include acquisition, partnership, management, private placement. View all BRSF news →
SEC Filings
Financial Highlights
Brain Scientific generated $215K in revenue over the trailing twelve months, retaining a 25.3% gross margin, operating income reached -$9.6M (-4478.1% operating margin), and net income was -$12.3M, reflecting a -5753.0% net profit margin. Diluted earnings per share stood at $-12.95. The company generated -$5.9M in operating cash flow. With a current ratio of 0.18, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
BRSF Company Profile & Sector Positioning
Brain Scientific (BRSF) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BRSF often look at related companies in the same sector, including Dynatronics Corp (DYNT), Cyduct Diagnostics Inc (CYDX), Electromedical T (EMED), Bionoid Pharma Inc (BINP), and QHSLab Inc (USAQ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BRSF's relative position within its industry.